Mechanism-based inactivation of porphobilinogen synthase: Substitution of ketone functionality in the substrate with a thioester

Bioorganic & Medicinal Chemistry Letters
1995.0

Abstract

The thioester (5) was found to inactivate the enzyme porphobilinogen synthase. Replacement of the ketone functionality in aminolevulinic acid (ALA), shown to be involved in Schiff-base linkage with an active site lysine residue, by a thioester moiety was found to result in loss of enzyme activity. A plausible mode of inactivation is proposed. Porphobilinogen synthase (PBGS, ALA-dehydratase) catalyzes the condensation of two molecules of 5-aminolevulinic acid (ALA, 1) to give porphobilinogen (PBG, 2), the heterocyclic precursor of all naturally occurring porphyrin and corrin cofactors. 1 The native enzyme in E. coli is an octamer of molecular weight 280 kDa (subunit: 35 kDa) and requires Zn(II) for catalysis. 2 The two molecules of ALA come to reside in the final product in an asymmetric fashion, one giving rise to the acetate (A) side chain and the other forming the propionate (P) side chain of porphobilinogen (Fig. 1). The proposed enzymatic mechanism involves formation of a Schiff-base intermediate between an active site lysine 3 and the C-4 carbonyl group of one of the ALA molecules denoted as P-side ALA since the propionate side chain of the product is derived from it. Subsequently the free amino group of the ALA-Schiff base intermediate undergoes Schiff-base formation with the second ALA molecule, denoted as the A-side ALA. Subsequent reactions lead to the formation of PBG (Fig. 2). 5-Chlorolevulinic acid was introduced as an inactivator of the enzyme by Seehra and Jordan. 4 Further work carried out by Jaffe and co-workers showed that the α-chloroketone functionality labelled an active site cysteine believed to be a ligand for the catalytic zinc. 5 Heterogeneous modification of the enzyme was observed as evidenced by the fact that at least two different cysteines were labelled. We now report the mechanism-based inactivation of the enzyme by using a modified substrate analog approach. Heteroatom modification of the C-3 methylene group of the substrate to produce the ester 4 and thioester 5 results in the generation of a potential scissile C-X (X=O, S) bond while minimising structural deviation. If the active site lysine involved in Schiff-base formation carried out nucleophilic attack at the ester or thioester functionality this could result in inactivation of the enzyme as depicted in Fig. 3.

Knowledge Graph

Similar Paper

Mechanism-based inactivation of porphobilinogen synthase: Substitution of ketone functionality in the substrate with a thioester
Bioorganic & Medicinal Chemistry Letters 1995.0
Structure of the Heme Biosynthetic Pseudomonas aeruginosa Porphobilinogen Synthase in Complex with the Antibiotic Alaremycin
Antimicrobial Agents and Chemotherapy 2010.0
Studies On uro'gen III synthase with modified bilanes
Bioorganic & Medicinal Chemistry Letters 1994.0
Deuterium isotope effects on porphobilinogen synthesis catalysed by 5-aminolaevulinic acid dehydratase
Bioorganic & Medicinal Chemistry Letters 1996.0
Synthesis and antibacterial activity of alaremycin derivatives for the porphobilinogen synthase
Bioorganic & Medicinal Chemistry Letters 2011.0
Purification, <i>N</i>-terminal amino acid sequence and properties of hydroxymethylbilane synthase (porphobilinogen deaminase) from <i>Escherichia coli</i>
Biochemical Journal 1986.0
Normal and abnormal heme biosynthesis. Part 7. Synthesis and metabolism of coproporphyrinogen-III analogues with acetate or butyrate side chains on rings C and D. Development of a modified model for the active site of coproporphyrinogen oxidase
Bioorganic &amp; Medicinal Chemistry 2011.0
5-p-Benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase
Journal of Medicinal Chemistry 1983.0
Inactivation of .gamma.-aminobutyric acid aminotransferase by (S,E)-4-amino-5-fluoropent-2-enoic acid and effect on the enzyme of (E)-3-(1-aminocyclopropyl)-2-propenoic acid
Journal of Medicinal Chemistry 1986.0
p-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli
Journal of Medicinal Chemistry 1977.0